PROVASMIN

Serial Number 75108939
Registration 2073689
800

Registration Progress

Application Filed
May 23, 1996
Under Examination
Approved for Publication
Feb 28, 1997
Published for Opposition
Apr 1, 1997
Registered
Jun 24, 1997

Trademark Image

PROVASMIN

Basic Information

Serial Number
75108939
Registration Number
2073689
Filing Date
May 23, 1996
Registration Date
June 24, 1997
Published for Opposition
April 1, 1997
Renewal Date
June 24, 2017
Drawing Code
1

Status Summary

Current Status
Active
Status Code
800
Status Date
Jul 5, 2017
Registration
Registered
Classes
005

Rights Holder

ALDAMA PHARMACEUTICALS, INC.

03
Address
3307 NW 7TH AVENUE
MIAMI, FL 33122

Ownership History

DAYTON LABORATORIES, INC.

Original Applicant
03
Miami, FL

DAYTON LABORATORIES, INC.

Owner at Publication
03
Miami, FL

DAYTON LABORATORIES, INC.

Original Registrant
03
Miami, FL

DAYTON PHARMACEUTICALS, INC.

New Owner After Registration #10
03
MIAMI, FL

PROPHARMA, INC.

New Owner After Registration #11
03
DORAL, FL

NEWPHARMA, INC.

New Owner After Registration #12
03
MIAMI, FL

ALDAMA PHARMACEUTICALS, INC.

New Owner After Registration #13
03
MIAMI, FL

Legal Representation

Attorney
Eric T. Fingerhut

USPTO Deadlines

Next Deadline
607 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 1997-06-24)
Due Date
June 24, 2027
Grace Period Ends
December 24, 2027

Application History

26 events
Date Code Type Description Documents
Sep 24, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 5, 2017 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) Loading...
Jul 5, 2017 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Jul 5, 2017 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Jul 5, 2017 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
May 25, 2017 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Apr 10, 2013 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 6, 2006 CFIT O CASE FILE IN TICRS Loading...
Oct 2, 2006 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Oct 2, 2006 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Oct 2, 2006 PLGL A ASSIGNED TO PARALEGAL Loading...
Sep 19, 2006 PLGL A ASSIGNED TO PARALEGAL Loading...
Sep 18, 2006 PLGL A ASSIGNED TO PARALEGAL Loading...
Jun 26, 2006 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jun 26, 2006 89AF I REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED Loading...
Aug 10, 2002 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jul 2, 2002 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Loading...
Jul 2, 2002 MAIL I PAPER RECEIVED Loading...
Jun 24, 1997 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 1, 1997 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 28, 1997 NPUB O NOTICE OF PUBLICATION Loading...
Jan 21, 1997 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 21, 1997 IUAA P USE AMENDMENT ACCEPTED Loading...
Dec 24, 1996 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Oct 21, 1996 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 11, 1996 IUAF S USE AMENDMENT FILED Loading...

Detailed Classifications

Class 005
over the counter medications used for treatment of capillary fragility; and nutritional supplements
First Use Anywhere: Oct 7, 1996
First Use in Commerce: Oct 7, 1996

Classification

International Classes
005